Melem Secret (HTDS) iPad Giveaway

TORONTO, May 12 /PRNewswire-FirstCall/ - Melem Secret (HTDS: http://melemsecret.com/index.php) announces its Spring To Me Giveaway.

This week Melem Secret launches a new website, and a variety of original natural products. To introduce these changes to new and existing customers, Melem Secret created a youtube video (http://www.youtube.com/watch?v=lp5RLfwGIY0) publicizing their Spring Contest. Viewers can sign up online to win a brand new Apple iPad and a selection of Melem Secret's skin nourishing supplements by May 14, 2010. Further information is available at www.MelemSecret.com/springtome.

This campaign aims to engage customers with the new web site, and to familiarize them with the Collagenna brand and products. Melem Secrets' products include; The Skin Defense complex that protects skin from the damages of time; The Baobab fruit supplement that promotes healthy and smooth skin; The Marine Collagen that produces radiant skin and healthy connective tissue.

Winners of Melem Secret's spring contest get to start spring with beautiful skin and a brand new iPad!

The company reminds its shareholders and followers to monitor PinkSheets.com Filing section and also our IR company web site section "PRESS RELEASES AND FILINGS" TAB http://www.minamargroup.net/ for non newsworthy corporate updates.

For any matters relating to retail investor queries or to send the company or its IR a message please click on the "INVESTOR SUPPORT" TAB, or the direct link http://www.minamargroup.net/helpdesk. In this regard, Mina Mar Group works diligently to answer and address all the pressing issues regarding its clients to the shareholders' satisfaction. MMG is in constant contact with the companies, addressing, obtaining, processing and processing all inquiries. Depending on the location of the issuer it may take up to several days, depending on the company's location and management's availability to address these pressing issues. MMG is often one of the advisors or IR companies utilized by the issuer. In a normal course of business and a pending transaction the issuer may opt to remain silent in order not to lose advantage to a competitor. MMG is mindful that sometimes shareholders want answers now, which for above reasons cannot be fulfilled on a timely basis.

Don't be a victim. Report a stock basher to authorities. The company is mindful that short sellers, the company competitors and stock bashers stalk small cap Pink Sheets listed companies with hidden agendas. Visit http://www.stockbasher.com/ and find out what criminal and civil actions the US authorities are taking against web sites like investorshub.com and other posters, and the remedies available to you as an individual investor. MMG encourages the readers to visit this investorshub.com blog and similar "investors" web sites with an open mind. Discover for yourself why and how USA small based businesses and the back bone of the economy suffer. Stay informed and do not allow entrepreneurs dreams, innovations, and their access to capital to be thwarted as "scalpers" and day traders vigorously day in and day out try to exploit and extinguish US innovation and progress for quick profits.

Filings for this event are currently being reviewed and will be filed with Pink Sheets and Client Support section in due course. To be included in company's email database for press releases, industry updates, and non-weekly activity in the company that may or may not be news released, please subscribe or opt in mailer at http://www.minamargroup.com/updates.

Safe Harbor Statement

Information in this news release may contain statements about future expectations, plans, prospects or performance of Hard to Treat Diseases Inc. that constitute forward-looking statements for purposes of the Safe Harbor Provisions under the Private Securities Litigation Reform Act of 1995. The words or phrases "can be", "expects", "may affect", "believed", "estimate", "project" and similar words and phrases are intended to identify such forward-looking statements. Hard to Treat Diseases Inc. cautions you that any forward-looking information provided by or on behalf of Hard to Treat Diseases Inc. is not a guarantee of future performance. None of the information in this press release constitutes or is intended as an offer to sell securities or investment advice of any kind. Hard to Treat Diseases Inc. 's actual results may differ materially from those anticipated in such forward-looking statements as a result of various important factors, some of which are beyond Hard to Treat Diseases Inc.'s control. In addition to those discussed in Hard to Treat Diseases Inc.'s press releases, public filings, and statements by Hard to Treat Diseases Inc. 's management, including, but not limited to, Hard to Treat Diseases Inc.'s estimate of the sufficiency of its existing capital resources, Hard to Treat Diseases Inc. 's ability to raise additional capital to fund future operations, Hard to Treat Diseases Inc.'s ability to repay its existing indebtedness, the uncertainties involved in estimating market opportunities, and in identifying contracts which match Hard to Treat Diseases Inc.'s capability to be awarded contracts. All such forward-looking statements are current only as of the date on which such statements were made. Hard to Treat Diseases Inc. does not undertake any obligation to publicly update any forward-looking statement to reflect events or circumstances after the date on which any such statement is made or to reflect the occurrence of unanticipated events.

CONTACT: For any investor relations matters, please contact www.minamargroup.net/helpdesk; Investor Relations Department Inquiry,www.minamargroup.net (IR); For (M&A) and Corporate Matters, www.minamargroup.com

SOURCE Hard to Treat Diseases